Assembly Biosciences (ASMB) Assets Growth (3y) (2013 - 2026)

Assembly Biosciences (ASMB) Assets Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Assembly Biosciences 431.63 Mn 205.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 41.51%
Dec 31, 2025 36.27%
Sep 30, 2025 25.47%
Jun 30, 2025 -17.42%
Mar 31, 2025 -15.26%
Dec 31, 2024 -14.56%
Sep 30, 2024 -26.15%
Jun 30, 2024 -23.94%
Mar 31, 2024 -24.53%
Dec 31, 2023 -21.54%
Sep 30, 2023 -44.76%
Jun 30, 2023 -39.10%
Mar 31, 2023 -35.75%
Dec 31, 2022 -33.10%
Sep 30, 2022 -18.36%
Jun 30, 2022 -15.94%
Mar 31, 2022 -14.38%
Dec 31, 2021 -10.67%
Sep 30, 2021 -4.18%
Jun 30, 2021 22.55%